Development of a core outcome set for myocardial infarction in clinical trials of traditional Chinese medicine: a study protocol
Open Access
Abstract
Introduction Myocardial infarction (MI) is the most dangerous complication in patients with coronary heart disease. In China, there is an increasing number of randomised controlled trials (RCTs) of traditional Chinese medicine (TCM) for treating MI. However, the inconsistency of outcome reporting means that a large number of clinical trials cannot be included in systematic reviews to provide the best evidence for clinical practice. The aim of this study is to develop a core outcome set (COS) for future TCM clinical trials of MI, which may improve the consistency of outcome reporting and facilitate the synthesis of data across studies in systematic reviews. Methods and analysis We will conduct a systematic review of MI clinical trials with any intervention. Semistructured interviews will be conducted to obtain the perspectives of patients with MI. The outcomes from the systematic review and semistructured interviews will be grouped and used to develop a questionnaire. The questionnaire will be developed as a supplement for the TCM syndromes of MI and will be constructed from the results of a systematic review, existing medical records and a cross-sectional study. Then two rounds of the Delphi survey will be conducted with different stakeholders (TCM experts and Western medicine experts in cardiovascular disease, methodologists, magazine editors and patients) to determine the importance of the outcomes. Only the TCM experts will need to response to the questionnaire for core TCM syndromes. A face-to-face consensus meeting will be conducted to create a final COS and recommend measurement time for each outcome. Ethics and dissemination This project has been approved by the Ethics Committee of Dongzhimen Hospital, Beijing University of Chinese Medicine. The final COS will be published and freely available. Trial registration number This study is registered with the Core Outcome Measures in Effectiveness Trials database as study 1243 (available at: http://www.comet-initiative.org/studies/details/1243).Keywords
Funding Information
- National Key R&D Program of China (2017YFC1700400)
- National Key R&D Program of China (2017YFC1700402)
- Fundamental Research Funds for the Central University (2019-JYB-JS-033)
This publication has 17 references indexed in Scilit:
- A taxonomy has been developed for outcomes in medical research to help improve knowledge discoveryJournal of Clinical Epidemiology, 2018
- Improved outcomes in patients with ST-elevation myocardial infarction during the last 20 years are related to implementation of evidence-based treatments: experiences from the SWEDEHEART registry 1995–2014European Heart Journal, 2017
- CONSORT Extension for Chinese Herbal Medicine Formulas 2017: Recommendations, Explanation, and ElaborationAnnals of Internal Medicine, 2017
- The COMET Handbook: version 1.0Trials, 2017
- A methodological approach for assessing the uptake of core outcome sets using ClinicalTrials.gov: findings from a review of randomised controlled trials of rheumatoid arthritisBMJ, 2017
- Clinical Research of Traditional Chinese Medicine Needs to Develop Its Own System of Core Outcome SetsEvidence-Based Complementary and Alternative Medicine, 2013
- Effects of Aroma Massage on Home Blood Pressure, Ambulatory Blood Pressure, and Sleep Quality in Middle-Aged Women with HypertensionEvidence-Based Complementary and Alternative Medicine, 2013
- Developing core outcome sets for clinical trials: issues to considerTrials, 2012
- OMERACT: An international initiative to improve outcome measurement in rheumatologyTrials, 2007
- OMERACT conference on outcome measures in rheumatoid arthritis clinical trials: introduction.1993